Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Designer drugs.

K N Vogtsberger

    Texas Medicine
    |July 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Designer drugs, synthetic analogs of psychoactive substances, pose significant risks due to their potent effects and toxic synthesis by-products. This review covers fentanyl, meperidine, and methamphetamine analogs, detailing their effects and clinical presentations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Injecting drug users who want treatment.

    The American journal of drug and alcohol abuse·1997
    Same author

    The relationship of methadone dose and other variables to outcomes of methadone maintenance.

    The American journal on addictions·1997
    Same author

    The intravenous injection of illicit drugs and needle sharing: an historical perspective.

    Journal of psychoactive drugs·1997
    Same author

    Evaluation of needle and syringe combinations.

    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1997
    Same author

    Illicit drug injectors in three Texas cities.

    The International journal of the addictions·1994
    Same author

    Program changes and retention on methadone.

    Journal of substance abuse treatment·1993
    Same journal

    Commentary: This Is Not a Drill.

    Texas medicine·2021
    Same journal

    Healthy Determination: Texas Physicians are Finding Better Ways to Address Their Patients' Social Determinants of Health.

    Texas medicine·2021
    Same journal

    Going Local: Accountable Health Organizations Could Help Combat Social Disparities at the Local Level.

    Texas medicine·2021
    Same journal

    Data Driven: Medicaid's Inspector General Focuses on Fraud Prevention, Not Just Prosecution.

    Texas medicine·2021
    Same journal

    Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).

    Texas medicine·2021
    Same journal

    Obstacles to Clear.

    Texas medicine·2021
    See all related articles

    Area of Science:

    • Forensic Chemistry
    • Pharmacology
    • Toxicology

    Background:

    • Designer drugs are synthetic compounds mimicking illicit substances.
    • Their illicit synthesis and unpredictable pharmacology pose public health risks.
    • Understanding these novel psychoactive substances is crucial for clinical and forensic settings.

    Purpose of the Study:

    • To review the pharmacology and clinical effects of designer drugs.
    • To describe the synthesis and toxicological profiles of specific designer drug classes.
    • To provide an overview of fentanyl, meperidine, and methamphetamine analogs.

    Main Methods:

    • Literature review of scientific databases.
    • Analysis of pharmacological and clinical data on designer drugs.

    Related Experiment Videos

  • Categorization of designer drugs into fentanyl, meperidine, and methamphetamine analogs.

    • Main Results:

    • Designer drugs exhibit potent psychoactive effects similar to their parent compounds.
    • Toxic by-products from synthesis contribute to adverse clinical presentations.
    • Fentanyl, meperidine, and methamphetamine analogs represent significant public health threats.

    Conclusions:

    • Designer drugs present unique challenges due to their variable potency and impurity profiles.
    • Clinical recognition and management require awareness of these emerging substances.
    • Further research is needed to fully elucidate the risks associated with designer drug use.